September 05, 2025

Extended-Release Risperidone Injection Receives FDA Approval

FDA approves Amneal’s risperidone extended-release injection for schizophrenia and Bipolar I maintenance.

Conexiant

September 05, 2025

Is Prenatal Chlorpyrifos Exposure Linked to Brain Changes?

Prenatal chlorpyrifos associated with magnetic resonance imaging changes, hypoperfusion, and motor slowing—without age/sex moderation, mediation, or connectivity effects.

Conexiant

September 04, 2025

'No Standard of Care' for GLP-1 Weaning

Without a defined standard of care for tapering GLP-1 medications, physicians must navigate patient management amid insurer restrictions and high discontinuation rates

KFF Health News

September 04, 2025

Medical Oddities: Sugar-Free, Cognition Fee?

This week: sugar-free brain costs, deadly selfies, tea for liver, knee creaks, and phone drama.

Conexiant

September 04, 2025

When to Refer for Subdural Hematomas

Chronic and recurrent subdural hematomas (SDH) are common in older, anticoagulated, and fragile patients. Traditional surgery often means recurrence, repeat procedures, and delays restarting anticoagulation.

Baptist Health South Florida

September 02, 2025

New Maintenance Option for Early Alzheimer’s Approved by FDA

FDA approves Leqembi IQLIK (lecanemab-irmb), a once-weekly subcutaneous autoinjector for maintenance treatment of early Alzheimer’s disease.

Conexiant

August 28, 2025

Study Identifies Age-Specific Prediabetes Mortality Risk

Researchers found in over 38,000 US adults that prediabetes was linked to higher mortality risk only in those aged 20 to 54 years.

Conexiant

August 27, 2025

Fast Walking Tied to Longer Life

As little as 15 minutes per day of fast walking was linked to 19% lower all-cause mortality.

Conexiant

August 27, 2025

Drug for Dizziness May Increase Falls

Researchers find elevated risk across adult age groups, not just in older adults.

Conexiant